🇺🇸 FDA
Patent

US 10182997

Liposomal curcumin for treatment of cancer

granted A61KA61K31/12A61K9/0019

Quick answer

US patent 10182997 (Liposomal curcumin for treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/12, A61K9/0019, A61K9/127, A61K9/1272